UPDATE 1-Proteon Therapeutics kidney drug fails key study, shares slump

Dec 13 (Reuters) - Proteon Therapeutics Inc said on
Tuesday that its experimental chronic kidney disease drug failed
to meet the main goal in a late-stage study, sending its shares
plunging 70...